A
Aaron Pollett
Researcher at University of Toronto
Publications - 102
Citations - 9443
Aaron Pollett is an academic researcher from University of Toronto. The author has contributed to research in topics: Cancer & Lynch syndrome. The author has an hindex of 37, co-authored 95 publications receiving 8620 citations. Previous affiliations of Aaron Pollett include Lunenfeld-Tanenbaum Research Institute & Mount Sinai Hospital, Toronto.
Papers
More filters
Journal ArticleDOI
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
TL;DR: The identification of colon cancer stem cells that are distinct from the bulk tumour cells provides strong support for the hierarchical organization of human colon cancer, and their existence suggests that for therapeutic strategies to be effective, they must target the cancer stem Cells.
Journal ArticleDOI
Variable Clonal Repopulation Dynamics Influence Chemotherapy Response in Colorectal Cancer
Antonija Kreso,Antonija Kreso,Catherine A. O’Brien,Catherine A. O’Brien,Peter van Galen,Olga I. Gan,Faiyaz Notta,Faiyaz Notta,Andrew M.K. Brown,Karen Ng,Jing Ma,Erno Wienholds,Cyrille F. Dunant,Aaron Pollett,Steven Gallinger,John Douglas Mcpherson,Charles G. Mullighan,Darryl Shibata,John E. Dick,John E. Dick +19 more
TL;DR: Combining DNA copy number alteration (CNA) profiling, sequencing, and lentiviral lineage tracking, this work followed the repopulation dynamics of 150 single lentivirus-marked lineages from 10 human colorectal cancers through serial xenograft passages in mice, showing that clones remained stable upon serial transplantation and Chemotherapy promoted the dominance of previously minor or dormant lineages.
Journal ArticleDOI
Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients
Robert P. Myers,Gilles Pomier-Layrargues,Richard Kirsch,Aaron Pollett,Andres Duarte-Rojo,David Wong,Melanie D. Beaton,Mark Levstik,Pam Crotty,Magdy Elkashab +9 more
TL;DR: Compared with the M probe, the FibroScan XL probe reduces TE failure and facilitates reliable LSM in obese patients, and lower liver stiffness cutoffs will be necessary when the XL probe is used to noninvasively assess liver fibrosis.
Journal ArticleDOI
Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study.
Mark A. Jenkins,Shinichi Hayashi,Anne Marie O'Shea,Lawrence J. Burgart,Thomas C. Smyrk,David Shimizu,Paul Waring,Andrew Ruszkiewicz,Aaron Pollett,Mark Redston,Melissa A. Barker,John A. Baron,Graham Casey,James G. Dowty,Graham G. Giles,Paul J. Limburg,Polly A. Newcomb,Joanne P. Young,Michael Walsh,Stephen N. Thibodeau,Noralane M. Lindor,Loic LeMarchand,Steven Gallinger,Robert W. Haile,John D. Potter,John L. Hopper,Jeremy R. Jass +26 more
TL;DR: There is little value in testing for DNA mismatch repair loss in tumors, or for germline mismatch repair mutations, for colorectal cancers diagnosed in patients before age 60 years with an MSPath score <1 (approximately 50%).
Journal ArticleDOI
Combined hereditary and somatic mutations of replication error repair genes result in rapid onset of ultra-hypermutated cancers.
Adam Shlien,Brittany Campbell,Richard de Borja,Ludmil B. Alexandrov,Daniele Merico,David C. Wedge,Peter Van Loo,Patrick S. Tarpey,Paul Coupland,Sam Behjati,Aaron Pollett,Tatiana Lipman,Abolfazl Heidari,Shriya Deshmukh,Na'ama Avitzur,Bettina Meier,Moritz Gerstung,Ye Hong,Diana M. Merino,Manasa Ramakrishna,Marc Remke,Roland Arnold,Gagan B. Panigrahi,Neha P. Thakkar,Karl P. Hodel,Erin E. Henninger,A. Yasemin Göksenin,Doua Bakry,George S. Charames,Harriet Druker,Jordan Lerner-Ellis,Matthew Mistry,Rina Dvir,Ronald Grant,Ronit Elhasid,Roula Farah,Glenn Taylor,Paul C. Nathan,Sarah Alexander,Shay Ben-Shachar,Simon C. Ling,Steven Gallinger,Shlomi Constantini,Peter B. Dirks,Annie Huang,Stephen W. Scherer,Richard Grundy,Carol Durno,Melyssa Aronson,Anton Gartner,M. Stephen Meyn,Michael D. Taylor,Zachary F. Pursell,Christopher E. Pearson,David Malkin,P. Andrew Futreal,Michael R. Stratton,Eric Bouffet,Cynthia Hawkins,Peter J. Campbell,Uri Tabori +60 more
TL;DR: A new mechanism of cancer progression is suggested in which mutations develop in a rapid burst after ablation of replication repair, which implies a threshold compatible with cancer-cell survival.